Committee for Advanced Therapies

The committee that is responsible for assessing the quality, safety and efficacy of advanced therapy medicines, including medicines classified as gene therapy, somatic cell therapy or tissue-engineered products. Abbreviated as CAT.

For more information, see Committee for Advanced Therapies (CAT).